Talam Biotech key facts
as of Oct 2026- Developer of environmental bio-remediation products designed to reduce toxins in crops and clean contaminated soil and water.
- Talam Biotech is valued at approximately $10.5M as of Oct 2026 (last reported valuation).
- It has raised $22.3M; the latest was Later Stage VC ($5.0M) in Jan 2025.
- Notable investors include Enterprise Ireland, Connecticut Innovations, AME Cloud Ventures, SVG Ventures|THRIVE, Cultivation Capital — 16 tracked in total.
- Status: Privately Held (backing).
Talam Biotech's last reported valuation, Jan 2025. Nothing priced has surfaced since.
- ·The complete investor list: 16 names
- ·Watch Talam Biotech: the Monday email on marks, rounds and moves
Talam Biotech funding rounds
No funding rounds for Talam Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Talam Biotech
16+Talam Biotech valuation
Talam Biotech's last reported valuation was $10.5 million in Jan 2025. No priced round, secondary trade or fund mark has surfaced since.
Talam Biotech investors
16 investors are on record for Talam Biotech, including Enterprise Ireland, Connecticut Innovations, AME Cloud Ventures and SVG Ventures|THRIVE. By type, the record holds 6 venture capital firms and 1 private equity firm.
About Talam Biotech
Developer of environmental bio-remediation products designed to reduce toxins in crops and clean contaminated soil and water. The company's microbial keys, derived from natural sources, reduce heavy metal uptake by inhibiting the bioavailability of heavy metals to plants, enabling microbes to reduce contaminants and remediate soil pollutants.
- Sector
- Materials and Resources
- HQ
- Groton, CT, United States
- Founded
- 2012
- Employees
- 16
- Website
- talam.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.